Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The KEAP1-NRF2 complex is the primary cellular mechanism for sensing and responding to oxidative and electrophilic stress. Kelch-like ECH-associated protein 1 (KEAP1) functions as a substrate adapter for the Cullin 3-based E3 ubiquitin ligase, which targets Nuclear factor erythroid 2-related factor 2 (NRF2) for proteasomal degradation under basal conditions (UniProt Q14145, Q16236). When cells encounter oxidative stress, reactive oxygen species (ROS) or electrophiles modify specific cysteine residues on KEAP1, disrupting the ubiquitination process. This allows NRF2 to accumulate, translocate to the nucleus, and bind to Antioxidant Response Elements (ARE) in the promoters of over 200 cytoprotective genes, including those for glutathione synthesis and detoxification enzymes (PubMed: 25911081). Pharmacological targeting of this complex aims to activate NRF2 to treat chronic inflammatory and degenerative diseases, such as chronic kidney disease and multiple sclerosis (PubMed: 30736422). However, the pathway is a double-edged sword; while it protects healthy cells, many cancers hijack NRF2 activation to survive oxidative stress and resist chemotherapy, making NRF2 inhibition a potential strategy in oncology (PubMed: 23435367).
Inhibition of KEAP1-mediated ubiquitination of NRF2, leading to NRF2 stabilization, nuclear translocation, and activation of the antioxidant response element (ARE) gene battery.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like ECH-associated protein 1-Nuclear factor erythroid 2-related factor 2 complex (KEAP1-NRF2).